Mayinglong Pharmaceutical Group Co., Ltd. Class ASSE: 600993

2025 Annual Report

Apr 25, 2026 · Issued by Mayinglong Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange

2025 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment